Astrana Health Files 8-K

Ticker: ASTH · Form: 8-K · Filed: Sep 4, 2024 · CIK: 1083446

Astrana Health, INC. 8-K Filing Summary
FieldDetail
CompanyAstrana Health, INC. (ASTH)
Form Type8-K
Filed DateSep 4, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-statements, regulation-fd

Related Tickers: APLS

TL;DR

Astrana Health (APLS) filed an 8-K on 9/4/24. Check it for Reg FD and financials.

AI Summary

Astrana Health, Inc. filed an 8-K on September 4, 2024, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Apollo Medical Holdings, Inc., is incorporated in Delaware and headquartered in Alhambra, California.

Why It Matters

This filing provides official updates and financial information from Astrana Health, Inc. to the public and investors.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and financial information without immediate, significant market-moving news.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves to report on Regulation FD disclosures and financial statements and exhibits, as of September 4, 2024.

What was Astrana Health, Inc. formerly known as?

Astrana Health, Inc. was formerly known as Apollo Medical Holdings, Inc., with a name change effective July 15, 2008.

Where are Astrana Health, Inc.'s principal executive offices located?

The principal executive offices of Astrana Health, Inc. are located at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, California 91801.

What is the company's state of incorporation?

Astrana Health, Inc. is incorporated in Delaware.

What is the SEC file number for Astrana Health, Inc.?

The SEC file number for Astrana Health, Inc. is 001-37392.

Filing Stats: 741 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2024-09-04 18:13:06

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Attached as Exhibit 99.1 to this Current Report on Form 8-K is a series of slides reflecting financial information about Astrana Health, Inc. (the "Company") for use by the Company in connection with upcoming presentations at conferences. The Company does not undertake to update the information contained in the attached presentation materials. The information contained in this Current Report on Form 8-K, including the exhibit referenced herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information will not be deemed an admission as to the materiality of any information contained herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation (September 2024). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking include words such as "forecast," "guidance," "projects," "estimates," "anticipates," "believes," "expects," "intends," "may," "plans," "seeks," "should," or "will," or the negative of these words or similar words. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in each such statement. A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the factors described in the Company's filings with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent quarterly reports on Form 10-Q. The Company does not undertake any responsibility to update any of these factors or to announce publicly any revisions to any of the forward-looking statements contained in this or any other document, whether as a result of new information, future events, or otherwise.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASTRANA HEALTH, INC. Date: September 4, 2024 By: /s/ Brandon K. Sim Name: Brandon K. Sim Title: Chief Executive Officer and President

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing